Free Trial
→ Banks aren’t ready for this altcoin—are you? (From Crypto 101 Media) (Ad) Free ACTU Stock Alerts

Actuate Therapeutics (ACTU) SEC Filings & 10K Form

Actuate Therapeutics logo
$6.52 -0.22 (-3.19%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$6.52 0.00 (0.00%)
As of 07/3/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Actuate Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
06/30/2025
12:01 PM		Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
12:02 PM		Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
12:03 PM		Actuate Therapeutics (Issuer)
Bios 2024 Co-Invest, LP (Reporting)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
11:08 AM		Actuate Therapeutics (Subject)
BIOS Fund I, LP (Filed by)
Form SCHEDULE 13D/A
06/26/2025
7:11 AM		Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2025
1:57 PM		Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2025
6:40 AM		Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2025
3:15 PM		Actuate Therapeutics (Subject)
BIOS Fund I, LP (Filed by)
Form SCHEDULE 13D/A
05/23/2025
3:37 PM		Actuate Therapeutics (Issuer)
THOMSON TODD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:05 PM		Actuate Therapeutics (Issuer)
RONNEBERG AMY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:05 PM		Actuate Therapeutics (Issuer)
Keyes Jason A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:05 PM		Actuate Therapeutics (Issuer)
Fletcher Aaron G.L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:05 PM		Actuate Therapeutics (Issuer)
Zabrowski Dan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:05 PM		Actuate Therapeutics (Issuer)
Sawhney Roger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
7:09 AM		Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2025
11:15 PM		Actuate Therapeutics (Filer)
Form EFFECT
04/16/2025
4:05 PM		Actuate Therapeutics (Filer)
Form 424B3
04/10/2025
4:28 PM		Actuate Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
04/02/2025
12:41 PM		Actuate Therapeutics (Issuer)
LYTLE PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
12:43 PM		Actuate Therapeutics (Issuer)
Mazar Andrew Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
12:44 PM		Actuate Therapeutics (Issuer)
SCHMITT DANIEL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
5:23 AM		Actuate Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/28/2025
5:00 AM		Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
3:30 PM		Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:00 PM		Actuate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/24/2024
3:05 PM		Actuate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/20/2024
7:45 PM		Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Form 4/A
08/20/2024
7:46 PM		Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Form 4/A
08/20/2024
7:46 PM		Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
Form 4/A
08/19/2024
7:59 PM		Actuate Therapeutics (Subject)
BIOS Fund I, LP (Filed by)
Form SC 13D
08/19/2024
4:25 PM		Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
8:12 PM		Actuate Therapeutics (Issuer)
Kairos SPV Fund LLC (Reporting)
Kairos Venture Opportunities I, L.P. (Reporting)
Kairos Venture Partners II, L.P. (Reporting)
Kairos-Actuate SPV, L.P. (Reporting)
THOMSON TODD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:46 PM		Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:49 PM		Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:51 PM		Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:54 PM		Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:56 PM		Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:44 PM		Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:48 PM		Actuate Therapeutics (Issuer)
Bios 2024 Co-Invest, LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
6:23 PM		Actuate Therapeutics (Issuer)
Sawhney Roger (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
6:23 PM		Actuate Therapeutics (Issuer)
RONNEBERG AMY L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad)

This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.

Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin
08/14/2024
6:25 PM		Actuate Therapeutics (Issuer)
Sawhney Roger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:26 PM		Actuate Therapeutics (Issuer)
RONNEBERG AMY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:27 PM		Actuate Therapeutics (Issuer)
Keyes Jason A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:28 PM		Actuate Therapeutics (Issuer)
LYTLE PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:29 PM		Actuate Therapeutics (Issuer)
SCHMITT DANIEL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:30 PM		Actuate Therapeutics (Issuer)
Zabrowski Dan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
4:14 PM		Actuate Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/14/2024
3:37 PM		Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
2:11 PM		Actuate Therapeutics (Filer)
Form POS EX
08/13/2024
1:50 PM		Actuate Therapeutics (Filer)
Form 424B4
08/12/2024
11:15 PM		Actuate Therapeutics (Filer)
Form EFFECT
08/12/2024
8:45 PM		Actuate Therapeutics (Issuer)
Keyes Jason A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
8:46 PM		Actuate Therapeutics (Issuer)
LYTLE PAUL J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
8:47 PM		Actuate Therapeutics (Issuer)
Mazar Andrew Paul (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
8:48 PM		Actuate Therapeutics (Issuer)
SCHMITT DANIEL M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
8:49 PM		Actuate Therapeutics (Issuer)
Zabrowski Dan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
5:57 PM		Actuate Therapeutics (Issuer)
Kairos SPV Fund LLC (Reporting)
Kairos Venture Opportunities I, L.P. (Reporting)
Kairos Venture Partners II, L.P. (Reporting)
Kairos-Actuate SPV, L.P. (Reporting)
THOMSON TODD S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
5:29 PM		Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
5:30 PM		Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
5:30 PM		Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
12:35 PM		Actuate Therapeutics (Filer)
Form CERT
08/12/2024
10:58 AM		Actuate Therapeutics (Filer)
Form 8-A12B/A
07/23/2024
5:01 AM		Actuate Therapeutics (Filer)
Form S-1/A
07/23/2024
5:01 AM		Actuate Therapeutics (Subject)
Form FWP
07/19/2024
7:01 AM		Actuate Therapeutics (Subject)
Form FWP
07/19/2024
6:58 AM		Actuate Therapeutics (Filer)
Form S-1/A
07/16/2024
1:41 PM		Actuate Therapeutics (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ACTU) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners
Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...
Crypto 101 Media | Sponsored
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...
American Alternative | Sponsored
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...
Paradigm Press | Sponsored
Trump’s New Order Could Boost Social Security Benefits by 400%
If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...
InvestorPlace | Sponsored
Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...
Crypto Swap Profits | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored